Txl Active Wart Remover Pads
NDC Package 83124-002-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Txl Active Wart Remover Pads is wash affected area: may soak wart in warm water for 5 minutes dry area thoroughly remove bandage strips by peeling backing off If necessary, cut medicated patch to fit wart carefully apply medicated plaster repeat procedure every 48 hours as needed (until wart is removed) for up to 12 week. Marketed by Kairos Trading Inc, this product is identified by NDC 83124-002 and is authorized under FDA application M028.

Identification & Billing

NDC Package Code
83124-002-01
Package Description
30 g in 1 BOX
Product Code
83124-002
11-Digit Billing Format
83124000201
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Txl Active Wart Remover Pads
Dosage Form
-
Usage Information
Wash affected area: may soak wart in warm water for 5 minutes dry area thoroughly remove bandage strips by peeling backing off If necessary, cut medicated patch to fit wart carefully apply medicated plaster repeat procedure every 48 hours as needed (until wart is removed) for up to 12 week

Regulatory & Marketing

Labeler Name
Kairos Trading Inc
FDA Application #
M028
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
05-16-2023
Listing Expiration
12-31-2024
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 83124-002-01 identifies a specific commercial package of 30 g in 1 box of Txl Active Wart Remover Pads, labeled by Kairos Trading Inc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Kairos Trading Inc on May 16, 2023. The current certification is valid through December 31, 2024.

How is this Kairos Trading Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 83124000201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
83124-002-01
11-Digit CMS (5-4-2)
83124-0002-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.